Vital KSK Holdings (TSE:3151) Cyclically Adjusted Revenue per Share: 円11,197.93 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3151 Vital KSK Holdings Inc TSE:3151
69 GF Score
Price 円1,635.00
GF Value 円1,326.27
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vital KSK Holdings Cyclically Adjusted Revenue per Share?

Vital KSK Holdings TSE:3151 +1.30% 69 Cyclically Adjusted Revenue per Share is 円11,197.93 as of Mar. 2026. GuruFocus rates TSE:3151 with a GF Score™ of 69/100 and a GF Value™ of 円1,326.27 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Vital KSK Holdings's adjusted revenue per share for the three months ended in Mar. 2026 was 円3,018.844. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円11,197.93 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Vital KSK Holdings's average Cyclically Adjusted Revenue Growth Rate was 3.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Vital KSK Holdings was 4.60% per year. The lowest was 0.80% per year. And the median was 3.50% per year.

As of today (2026-07-20), Vital KSK Holdings's current stock price is 円1635.00. Vital KSK Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円11,197.93. Vital KSK Holdings's Cyclically Adjusted PS Ratio of today is 0.15.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vital KSK Holdings was 0.15. The lowest was 0.07. And the median was 0.11.


Vital KSK Holdings  (TSE:3151) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Vital KSK Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1635.00/11197.93
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Vital KSK Holdings was 0.15. The lowest was 0.07. And the median was 0.11.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Vital KSK Holdings Cyclically Adjusted Revenue per Share Related Terms


Vital KSK Holdings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Vital KSK Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vital KSK Holdings Cyclically Adjusted Revenue per Share Chart

Vital KSK Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,509.71 9,923.78 10,279.43 10,871.45 11,197.93

Vital KSK Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,871.45 10,988.52 11,080.07 11,207.42 11,197.93

TSE:3151 vs MCK, CAH, COR: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Vital KSK Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vital KSK Holdings Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vital KSK Holdings's Cyclically Adjusted PS Ratio falls into.


TSE:3151
69GF Score
Vital KSK Holdings Inc TSE:3151
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vital KSK Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vital KSK Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3018.844/112.7000*112.7000
=3,018.844

Current CPI (Mar. 2026) = 112.7000.

Vital KSK Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 2,325.526 98.100 2,671.629
201609 2,154.917 98.000 2,478.155
201612 2,329.198 98.400 2,667.689
201703 2,067.894 98.100 2,375.654
201706 2,185.092 98.500 2,500.100
201709 2,091.608 98.800 2,385.873
201712 2,345.773 99.400 2,659.644
201803 2,015.544 99.200 2,289.837
201806 2,161.855 99.200 2,456.059
201809 2,037.378 99.900 2,298.423
201812 2,300.761 99.700 2,600.760
201903 2,046.749 99.700 2,313.627
201906 2,177.884 99.800 2,459.394
201909 2,186.181 100.100 2,461.365
201912 2,284.092 100.500 2,561.365
202003 2,020.272 100.300 2,270.036
202006 2,458.249 99.900 2,773.220
202009 2,392.205 99.900 2,698.714
202012 2,573.650 99.300 2,920.950
202103 2,321.336 99.900 2,618.764
202106 2,587.792 99.500 2,931.097
202109 2,601.272 100.100 2,928.705
202112 2,861.865 100.100 3,222.100
202203 2,585.774 101.100 2,882.460
202206 2,709.064 101.800 2,999.131
202209 2,824.228 103.100 3,087.202
202212 2,977.986 104.100 3,224.006
202303 2,644.096 104.400 2,854.307
202306 2,804.136 105.200 3,004.051
202309 2,935.128 106.200 3,114.773
202312 3,066.019 106.800 3,235.396
202403 2,760.453 107.200 2,902.081
202406 2,925.320 108.200 3,046.983
202409 3,036.850 108.900 3,142.819
202412 3,318.883 110.700 3,378.845
202503 2,848.259 111.100 2,889.278
202506 3,070.495 111.700 3,097.984
202509 3,147.355 112.000 3,167.026
202512 3,399.959 113.000 3,390.933
202603 3,018.844 112.700 3,018.844

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円11,197.93 mean?
Vital KSK Holdings (TSE:3151) has a Cyclically Adjusted Revenue per Share of 円11,197.93 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Vital KSK Holdings and its competitors.
Is Vital KSK Holdings' Cyclically Adjusted Revenue per Share too high?
Vital KSK Holdings' current Cyclically Adjusted Revenue per Share is 円11,197.93. Overall, Vital KSK Holdings has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' Cyclically Adjusted Revenue per Share compare to MCK and CAH?
Vital KSK Holdings' Cyclically Adjusted Revenue per Share of 円11,197.93 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Vital KSK Holdings and its competitors. Vital KSK Holdings's current Cyclically Adjusted Revenue per Share is 円11,197.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,326.27, compared to a current price of 円1,635.00 — trading 23.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円11,197.93. Vital KSK Holdings' overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current Cyclically Adjusted Revenue per Share is 円11,197.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?

Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued. The current stock price of 円1,635.00 is trading 23.3% above its estimated GF Value™ of 円1,326.27. GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.

Key valuation signals for TSE:3151:

  • Cyclically Adjusted Revenue per Share: 円11,197.93
  • GF Value™: 円1,326.27 vs. price of 円1,635.00 (23.3% above fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vital KSK Holdings Business Description

Address 1-1-12 Tsurumaki, Setagaya-ku, JPN, 154-0016
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
69GF Score

Get the complete analysis for TSE:3151

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,635.00
Price
円1,326.27
GF Value